Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 476 M469 M498 M471 M478 M478 M 1.93 B Research & development 156 M———172 M180 M — Operating income 321 M357 M256 M610 M435 M530 M 1.83 B Non-Operating Income, Total 7 M2 M7 M33 M6 M7 M 53 M Interest expense, net of interest capitalized 39 M39 M41 M37 M32 M36 M 146 M Non-Operating Income, excl. Interest Expenses -32 M-37 M-34 M-4 M-26 M-29 M -93 M Unusual income/expense —————— — Pretax income 213 M299 M342 M63 M342 M440 M 1.19 B Equity in earnings ———100 K—— — Taxes 35 M51 M49 M33 M40 M89 M 211 M Non-controlling/minority interest -6 M-4 M-2 M-108 M-3 M1 M -112 M After tax other income/expense —————— — Net income before discontinued operations 184 M252 M295 M138 M305 M350 M 1.09 B Discontinued operations —————— — Net income 184 M252 M295 M138 M305 M350 M 1.09 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 183 M251 M294 M139 M304 M349 M 1.09 B Basic earnings per share (Basic EPS) 1.622.222.611.242.713.11 9.67 Diluted earnings per share (Diluted EPS) 1.612.222.61.242.693.1 9.63 Average basic shares outstanding 113 M112.9 M112.5 M112.7 M112.3 M112.1 M — Diluted shares outstanding 113.5 M113.3 M113 M113.1 M112.9 M112.6 M — EBITDA 286 M320 M413 M809 M410 M478 M 2.11 B EBIT 208 M357 M256 M610 M331 M399 M 1.6 B Cost of revenue 1.16 B1.19 B1.27 B864 M1.09 B1.11 B 4.33 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 78 M119 M157 M199 M79 M79 M 514 M